Unlearn.AI
-
MedCity Pivot Podcast: A Conversation With Unlearn.AI CEO About Clinical Trials
The founder and CEO of Unlearn.AI seeks to make clinical trials more efficient and less costly by leveraging its Digital Twin technology. If the company is successful, drugs could potentially be brought to market sooner and in a cost effective manner.
-
Don’t miss the MedCity INVEST PharmaTech virtual conference July 26
The conference highlights the convergence of digital health and drug development. Among the panel discussions are a focus on the state of AI in drug discovery and the future of digital medicines. A startup pitch contest spotlights companies seeking to improve clinical trials. Register for free today!
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Creating better alignment between digital and pharma sectors
At the MedCity INVEST PharmaTech virtual conference July 26, strategies and alignment between digital and pharma companies will be a major theme of the conference. Register now to join the conversation.
-
Pharma, Artificial Intelligence, BioPharma
AI startup Unlearn adds $50M for better, faster, smaller & cheaper clinical trials
Unlearn.AI’s Series B round follows a positive European Medicines Agency draft opinion finding that the company’s artificial intelligence technology can be used in Phase 2 and Phase 3 clinical trials. The startup is now on the hunt for pharmaceutical partners that want to use this “digital twin” technology to speed up their clinical research.
-
Devices & Diagnostics, Pharma, BioPharma
Life sciences use of digital twins mirrors its application in other industries
Life sciences companies are using “digital twins” for everything from drug discovery to manufacturing. A panel of experts at MedCity News’ INVEST Digital Health conference discussed how this capability to run virtual simulations is changing practices now while also shaping the industry for the years to come.
-
BioPharma, Health Tech, Payers
Funding Roundup: Company creating ‘digital twins’ for clinical trials raises $12M
Unlearn.AI, a comapny using machine learning to generate control patients for clinical trials, raised a $12 million series A round. Several other startups shared funding news this week.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
